Literature DB >> 1234507

The effect of intramuscular salbutamol in asthmatics.

J Ingram, J Gaddie, C Skinner, K N Palmer.   

Abstract

1 In a double-blind placebo controlled dose-response experiment in six asthmatic patients with reversible airways obstruction the effect of i.m. salbutamol (4 mug/kg, 8 mug/kg or 12 mug/kg) was assessed by improvement in spirometry and change in pulse rate. 2 Salbutamol (8 mug/kg) resulted in a mean increase in FEV1 of 1 litre and a mean increase in pulse rate of 7 beats/minute. 3 It was concluded that salbutamol (8 mug/kg) was the optimal dose.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234507      PMCID: PMC1402584          DOI: 10.1111/j.1365-2125.1975.tb01585.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  SElectivity of broncholidlator action of salbutamol in asthmatic patients.

Authors:  J W Paterson; R J Evans; F J Prime
Journal:  Br J Dis Chest       Date:  1971-01

2.  Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.

Authors:  D A Warrell; D G Robertson; J N Howes; M E Conolly; J W Paterson; L J Beilin; C T Dollery
Journal:  Br Med J       Date:  1970-01-10

3.  Effect of salbutamol on spirometry and blood-gas tensions in bronchial asthma.

Authors:  K N Palmer; M L Diament
Journal:  Br Med J       Date:  1969-01-04

4.  Immunosurveillance and cancer.

Authors:  A E Papatestas; A E Kark
Journal:  Lancet       Date:  1970-11-21       Impact factor: 79.321

5.  Comparison of two oral selective beta2-adrenergic stimulant drugs in bronchial asthma.

Authors:  J S Legge; J Gaddie; K N Palmer
Journal:  Br Med J       Date:  1971-03-20

6.  Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation.

Authors:  Y F Choo-Kang; S S Parker; I W Grant
Journal:  Br Med J       Date:  1970-11-21
  6 in total
  2 in total

1.  Intramuscular salbutamol in acute asthma.

Authors:  P D Semple; J S Legge; T Habeshaw
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Determination of the optimum dose of subcutaneous salbutamol in asthmatic patients.

Authors:  T J Coady; C J Stewart; H J Davis
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.